Investor Relations

Overview

Boston Therapeutics, Inc. (OTCQB: BTHE)

Boston Therapeutics, headquartered in Manchester, NH, is a pharmaceutical company focused on the development and commercialization of novel compounds based on complex carbohydrate chemistry to address unmet medical needs in diabetes.

Investor Relations

Anthony Squeglia
Chief Financial Officer
1750 Elm Street
Suite 103
Manchester, NH 03104
(603) 935-9799
(603) 685-4784
anthony.squeglia@bostonti.com

Stock Quote